Targeted investor network Brookline differentiates with a non-institutional, global family office and high net worth network that acts as a curator for early stage venture and growth equity opportunities, offering access to patient capital ideal for emerging growth clients and potential funding rounds beyond traditional banks.

Growth financing appetite Their service suite spans Pre-IPO financings, IPOs, Secondaries, PIPEs and strategic capital markets advisory, signaling readiness to engage clients at multiple funding stages and to tailor capital solutions for rapid expansion or liquidity events.

International reach Brookline maintains a significant international presence with investor interest from Canada, China, Hong Kong, Italy, Korea, and the U.K., presenting opportunities for cross-border fundraising, regulatory navigation support, and global strategic partnerships.

Industry engagement Active participation in industry collaborations and events, such as TRP supply chain and manufacturing summits, indicates opportunities to connect with technology-driven healthcare and radiopharmaceutical companies seeking advisory and capital market support.

Leadership depth With senior bankers each bringing over 25 years of capital markets and advisory experience, Brookline offers credibility and deal execution capability that can be leveraged when targeting mid-market growth companies needing sophisticated advisory and execution for complex financings.